Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Crispr Therapeutics Ag (CRSP)

Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,234,860
  • Shares Outstanding, K 84,918
  • Annual Sales, $ 371,210 K
  • Annual Income, $ -153,610 K
  • 60-Month Beta 1.68
  • Price/Sales 10.94
  • Price/Cash Flow N/A
  • Price/Book 2.10
Trade CRSP with:

Options Overview Details

View History
  • Implied Volatility 53.61% ( -0.32%)
  • Historical Volatility 44.34%
  • IV Percentile 23%
  • IV Rank 22.05%
  • IV High 96.14% on 10/06/23
  • IV Low 41.58% on 09/19/23
  • Put/Call Vol Ratio 0.28
  • Today's Volume 3,525
  • Volume Avg (30-Day) 6,110
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 76,704
  • Open Int (30-Day) 71,984

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -1.44
  • Number of Estimates 12
  • High Estimate -1.00
  • Low Estimate -1.83
  • Prior Year -1.41
  • Growth Rate Est. (year over year) -2.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.42 +14.21%
on 09/06/24
51.99 -4.62%
on 09/18/24
+1.74 (+3.64%)
since 08/16/24
3-Month
43.42 +14.21%
on 09/06/24
63.68 -22.13%
on 07/16/24
-10.98 (-18.13%)
since 06/18/24
52-Week
37.55 +32.06%
on 10/23/23
91.10 -45.57%
on 02/22/24
+1.95 (+4.09%)
since 09/18/23

Most Recent Stories

More News
1 Biotech Stock Down 62% to Buy and Hold

It's an excellent opportunity to buy shares of what could become a biotech giant on the dip.

CRSP : 49.59 (-0.56%)
3 No-Brainer Biotech Stocks to Buy With $200 Right Now

An investment in these players today could score a big win down the road.

LLY : 904.97 (-0.13%)
GS : 484.58 (-0.17%)
NVO : 132.06 (+0.05%)
VKTX : 64.45 (+2.40%)
MRNA : 69.86 (-2.96%)
CRSP : 49.59 (-0.56%)
Looking for Stock Bargains With Room to Run? Try This.

Investing tips from Bill Mann, The Motley Fool's director of small-cap research.

WBA : 9.01 (-0.55%)
AAPL : 220.69 (+1.80%)
AMZN : 186.43 (-0.24%)
EXPE : 139.65 (+0.90%)
DENN : 6.68 (+1.06%)
CBRL : 41.56 (-1.84%)
JACK : 44.15 (+1.19%)
BJRI : 31.67 (-1.80%)
SABR : 3.24 (+0.31%)
EDIT : 3.88 (+0.52%)
CRSP : 49.59 (-0.56%)
DESP : 12.55 (+0.08%)
Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?

Is the potential upside for CRISPR Therapeutics too massive to ignore?

CRSP : 49.59 (-0.56%)
3 Monster Biotech Stocks to Buy Before 2025

These companies are nearly in the sweet spot of risk versus reward in biotech.

IOVA : 10.17 (-2.40%)
CRSP : 49.59 (-0.56%)
How major US stock indexes fared Wednesday, 8/28/2024

Losses for several big technology companies pulled the stock market lower

MNR : 16.54 (-0.18%)
CRSP : 49.59 (-0.56%)
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

The companies are chasing major innovations.

CRSP : 49.59 (-0.56%)
LLY : 904.97 (-0.13%)
PFE : 29.75 (-0.27%)
VKTX : 64.45 (+2.40%)
Appeals court says the District of Columbia can proceed with its antitrust lawsuit against Amazon

A federal appeals court has revived an antitrust lawsuit the District of Columbia brought against Amazon

CRSP : 49.59 (-0.56%)
Got the Market Sell-Off Blues? Do These 3 Things Right Now

You aren't powerless in the face of what the market throws at you.

CRSP : 49.59 (-0.56%)
AMGN : 332.92 (+0.04%)
ABT : 114.88 (-2.75%)
Is It Too Late to Buy Vertex Pharmaceuticals Stock?

Shares of the rare disease drugmaker are already up more than 40% over the past year.

CRSP : 49.59 (-0.56%)
MRK : 118.64 (+0.30%)
PFE : 29.75 (-0.27%)
VRTX : 474.16 (-1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CRISPR Therapeutics AG is a leading gene editing company focused on developing CRISPR/Cas9-based therapeutics. The company is rapidly leveraging its CRISPR/Cas9 gene-editing platform to make therapies for the treatment of hemoglobinopathies, cancer, diabetes and other diseases.

See More

Key Turning Points

3rd Resistance Point 54.14
2nd Resistance Point 53.06
1st Resistance Point 51.33
Last Price 49.59
1st Support Level 48.52
2nd Support Level 47.44
3rd Support Level 45.71

See More

52-Week High 91.10
Fibonacci 61.8% 70.64
Fibonacci 50% 64.32
Fibonacci 38.2% 58.01
Last Price 49.59
52-Week Low 37.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar